rs2230201 polymorphism may dictate complement C3 levels and response to treatment in chronic hepatitis C patients

E-ISSN： 1365-2893|22|2|184-191

ISSN： 1352-0504

Source： JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol.22, Iss.2, 2015-02, pp. : 184-191

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of complement component C4 in treatment response and disease progression in chronic hepatitis C patients

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 8, 2015-08 ,pp. : 671-674

John Wiley & Sons Inc

Access to resources Recommend Favorite

Serum ferritin levels in chronic hepatitis C patients during antiviral therapy and prediction of treatment response

By Barut Sener Günal Özgür Erkorkmaz Unal

Scandinavian Journal of Infectious Diseases, Vol. 44, Iss. 10, 2012-10 ,pp. : 761-765

Informa Healthcare

Access to resources Recommend Favorite

Vitamin D levels may explain the racial differences in response rates to antiviral therapy for chronic hepatitis C

HEPATOLOGY, Vol. 54, Iss. 4, 2011-10 ,pp. : 1489-1489

John Wiley & Sons Inc

Access to resources Recommend Favorite

CCR5 Promoter Polymorphism Influences the Interferon Response of Patients with Chronic Hepatitis C in Japan

Intervirology, Vol. 47, Iss. 2, 2004-06 ,pp. : 114-120

Karger

Access to resources Recommend Favorite

Impact of Added Fluvastatin to Standard-of-Care Treatment on Sustained Virological Response in Naïve Chronic Hepatitis C Patients Infected with Genotypes 1 and 3

Intervirology, Vol. 57, Iss. 1, 2013-09 ,pp. : 23-30

Karger

Access to resources Recommend Favorite